Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial

Author(s):
Noordman, B.J.; Verdam, M.G.E.; Lagarde, S.M.; Shapiro, J.; Hulshof, M.C.C.M.; Henegouwen, M.I.V.; Wijnhoven, B.P.L.; Nieuwenhuijzen, G.A.P.; Bonenkamp, J.J.; Cuesta, M.A.; Plukker, J.T.M.; Bilgen, E.J.S.; Steyerberg, E.W. (0000-0002-7787-0122); Gaast, A. van der; Sprangers, M.A.G.; Lanschot, J.J.B. van; CROSS Study Grp
Published
2018
Publication type
Article / Letter to editor
esophageal cancerneoadjuvant chemoradiotherapyhealthrelated quality of life
Date issued
2018-02-28
Language
English
Is part of
Annals of Oncology (2018), Vol. 29, no. 2, p. 445-451
hdl
1887/95454
doi
10.1093/annonc/mdx726